Hématologie
![Hématologie](/e-parus/00/00/1A/F5/image.jpg)
Hématologie is the official organ of the French Society of Hematology. It publishes review articles in all areas of hematology, written by the best specialists in these fields. These reviews are generally solicited by members of the editorial board, but direct submissions are welcome. Regardless of the mode of submission, manuscripts are peer-reviewed and revisions are, in most cases, requested before publication. The journal also provides a forum for interns and junior faculty to comment on recent major publications or papers from international haematology meetings. The journal also publishes the proceedings of the annual meeting of the French Society of Hematology. Articles may be submitted in French or English.
It is intended for hematologists, as well as students in training (DES, AFSA, etc.). It covers all hematological diseases, both malignant and benign. Hématologie (Éditions John Libbey Eurotext) publishes, in French or in English, reviews, anatomical cases, forums for ethical reflection, recommendations from learned societies and cooperative groups, as well as short reports on current literature in haematology. It also features "Residents' Corner" and "How I treat", which give the floor to hematology residents and senior specialists respectively. Articles are most often solicited by the editorial staff, but any proposal for collaboration will be considered with interest.
English e-section
Ahead of print
Breast implant-associated anaplastic large-cell lymphoma: from diagnosis to molecular sequencing
Camille Laurent, Corinne Haioun, Philippe Gaulard
Open Access
Myeloma before the age of 40: a French retrospective studyRunning title: Myeloma before the age of 40
Alexis Caulier, Bruno Royer
Open Access
The immune microenvironment and immunotherapy of multiple myeloma
Nicolas Gazeau, Salomon Manier
Open Access
Hereditary afibrinogenaemia: from genetics to treatments
Alessandro Casini, Françoise Bridey, Philippe de Moerloose
Open Access
Prognostic factors in diffuse large B-cell lymphoma at diagnosis (excluding the International Prognostic Index)
Julien Calvani, Véronique Meignin, Laëtitia Vercellino, Catherine Thieblemont
Open Access
Indications and procedure for CAR T-cell infusion
Jérôme Paillassa, Catherine Thieblemont
Open Access
Optimising the evaluation of therapeutic response to first-line treatment of diffuse large B cell lymphoma
Fabrice Jardin
Open Access
Mechanisms of resistance to targeted therapies
Romain Guièze
Open Access
Pre-therapeutic assessment of chronic lymphocytic leukaemia: what are the genetic tests and why?
Fanny Baran-Marszak
Open Access
Developments in thrombotic thrombocytopenic purpura and ADAMTS13
Bérangère Joly, Nicolas Beranger, Ygal Benhamou, Paul Coppo, Agnès Veyradier
Open Access
The genomic landscape of adult B-cell precursor acute lymphoblastic leukaemia
Marie Passet, Ibrahima Ba, Emmanuelle Clappier
Open Access
Congenital factor XIII deficiency: diagnosis, prevalence and treatment modalities in 2020
Lucia Rugeri, Séverine Bouttefroy, Émilie Jousselme, Christophe Nougier, Sandrine Meunier
Open Access
End-of-life platelet transfusion in haematological malignancies: a review
Julie Moracchini, Audrey Seigeot, Étienne Daguindau, Aurélie Godard-Marceau, Régis Aubry, Sandra Frache
Open Access
Personalised treatment for haemophilia
Yesim Dargaud
Open Access
Occupational exposure and risk of lymphomas
Jérôme Paillassa, Audrey Petit
Open Access
Next-generation sequencing in patients with hairy cell leukaemia (HCL)
Margaux Wiber, Elsa Maitre, Xavier Troussard
Open Access
New molecular classifications of diffuse large-cell lymphomas
Fabrice Jardin
Open Access
Germline RUNX1 mutations/deletions and genetic predisposition to haematological malignancies
Iléana Antony-Debré, Nicolas Duployez
Open Access
Pathophysiology and abnormalities of haemostasis in intensive care patients with COVID-19
Bérangère Joly, Nicolas Béranger, Maxime Delrue, Marie Neuwirth, Nathalie Itzhar-Baïkian, Arezki Hadj-Ali, Alain Stepanian, Agnes Veyradier, Virginie Siguret
Open Access
Sickle cell disease and the risk of malignant haemopathies
Françoise Bernaudin, Mathieu Kuentz, Yves Beuzard
Open Access
Enhancers, spatial chromosome structuring and pathological changes: towards a better understanding of complex genome alterations
Éric Soler
Open Access
Haemoglobin and haemoglobinopathies at the forefront of the 21st century
Yves Beuzard
Open Access
Wiskott-Aldrich syndrome
Isabelle Pellier, Charline Miot, Nizar Mahlaoui, Alain Fischer
Open Access
Neutrophil extracellular traps: key drivers of severe COVID-19
Cécile Oury, Thomas Marichal
Open Access
Sialylation and thrombocytopenia
Dominique Lasne, Delphine Borgel, Alexandre Kauskot
Open Access
Biological aspects of minimal residual disease in acute leukaemia
Claude Preudhomme, Adriana Plesa, Christophe Roumier
Open Access